During the past decade, Instituto Medico Elsa Perez SRL (IMEP) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Medico Elsa Perez SRL (IMEP)" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Medico Elsa Perez SRL (IMEP)" are "Cardiovascular Disease" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "Instituto Medico Elsa Perez SRL (IMEP)" in a lesser frequency.

Most popular intervention types in "Instituto Medico Elsa Perez SRL (IMEP)" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Medico Elsa Perez SRL (IMEP)" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Medico Elsa Perez SRL (IMEP)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Instituto Medico Elsa Perez SRL (IMEP), undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Medico Elsa Perez SRL (IMEP), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".